News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,320 Results
Type
Article (1930)
Company Profile (2)
Press Release (67388)
Section
Business (21551)
Career Advice (9)
Deals (4564)
Drug Development (8185)
FDA (1809)
Job Trends (806)
News (37148)
Policy (3566)
Tag
Academia (91)
Alliances (8127)
Alzheimer's disease (117)
Approvals (1818)
Artificial intelligence (8)
Bankruptcy (8)
Best Places to Work (584)
Biosimilars (12)
Breast cancer (11)
Cancer (131)
Career advice (9)
Cell therapy (14)
Clinical research (6933)
Collaboration (49)
Compensation (6)
COVID-19 (181)
C-suite (7)
Data (129)
Diabetes (10)
Diagnostics (589)
Drug discovery (11)
Duchenne muscular dystrophy (6)
Earnings (7514)
Events (6889)
Executive appointments (31)
FDA (1885)
Funding (31)
Gene therapy (10)
GLP-1 (36)
Government (233)
Healthcare (1073)
Infectious disease (185)
Inflammatory bowel disease (14)
Intellectual property (6)
IPO (1613)
Job creations (242)
Job search strategy (9)
Layoffs (6)
Legal (948)
Liver cancer (15)
Lung cancer (21)
Lymphoma (7)
Manufacturing (21)
Medical device (1120)
Medtech (1121)
Mergers & acquisitions (3005)
Metabolic disorders (28)
Neuroscience (144)
NextGen Class of 2024 (222)
Non-profit (61)
Northern California (106)
Obesity (11)
Parkinson's disease (12)
Patents (11)
People (4957)
Phase I (1883)
Phase II (2898)
Phase III (2638)
Pipeline (48)
Postmarket research (241)
Preclinical (653)
Radiopharmaceuticals (21)
Rare diseases (18)
Real estate (600)
Regulatory (2532)
Reports (6)
Research institute (91)
Series A (10)
Southern California (89)
Startups (426)
Supply chain (5)
United States (857)
Vaccines (19)
Date
Today (19)
Last 7 days (64)
Last 30 days (232)
Last 365 days (3296)
2024 (3269)
2023 (3829)
2022 (7024)
2021 (6396)
2020 (5885)
2019 (3878)
2018 (3014)
2017 (3572)
2016 (3185)
2015 (4051)
2014 (3033)
2013 (2604)
2012 (2784)
2011 (2923)
2010 (2675)
Location
Africa (79)
Arizona (5)
Asia (21171)
Australia (2469)
California (225)
Canada (191)
China (95)
Connecticut (10)
Europe (12296)
Florida (12)
Georgia (5)
Illinois (13)
India (6)
Japan (40)
Maryland (61)
Massachusetts (163)
Minnesota (22)
New Jersey (112)
New York (94)
North Carolina (50)
Northern California (106)
Pennsylvania (33)
South America (107)
Southern California (89)
Texas (12)
Utah (7)
Virginia (11)
69,320 Results for "engeneic pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
enGene to Participate in Upcoming Investor Conferences
November 25, 2024
·
1 min read
Press Releases
EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment
September 25, 2024
·
3 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
Business
EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia
EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announced strategic partnerships with Singapore Institute of Advanced Medicine Holdings and Singapore Medical Incorporation.
June 6, 2024
·
3 min read
Press Releases
enGene Reports Full Year 2024 Financial Results and Provides a Business Update
December 19, 2024
·
9 min read
Press Releases
enGene Announces $60 Million Private Placement Financing
October 28, 2024
·
5 min read
Press Releases
enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
November 6, 2024
·
1 min read
Genetown
enGene to Present at the Jefferies Global Healthcare Conference
enGene Holdings Inc. today announced that Jason Hanson, Chief Executive Officer, will present a corporate overview at the Jefferies Global Healthcare Conference in New York City, on June 5, 2024, at 12:30 p.m. ET.
May 29, 2024
·
1 min read
Press Releases
Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics
October 2, 2024
·
3 min read
Business
enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress
enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”) today announced its financial results for the first quarter ended January 31, 2024.
March 11, 2024
·
9 min read
1 of 6,932
Next
